Nia Therapeutics announced the publication of the first in vivo validation of its wireless, implantable brain-computer ...
Elon Musk announces Neuralink brain implants will enter "high-volume" production by 2026, helping paralyzed patients control ...
Summary • Datasea Inc. (DTSS) shares surged 20.3% intraday to $0.823 following a strategic collaboration announcement.• The ...
Investing.com -- Datasea Inc. (NASDAQ:DTSS) stock surged 11.5% Monday after the company announced a strategic collaboration with Nanjing Linghang Intelligent Aviation Technology to apply its acoustic ...
Acoustic Enhancement Technology Expands into the Multi-Billion-Dollar Non-Invasive BCI and Healthcare Applications Market ...
Datasea (DTSS) announced that its China operating subsidiary, Datasea Jingwei Information Technology Co., entered into a strategic collaboration ...
Elon Musk Neuralink Boost production of brain implants and automate surgical procedures starting in 2026, advancing clinical trials at University of Miami.
Visitors will experience neural-click speed testing, gesture creation and smart-screen control powered by the Mudra LinkYokneam Illit, Israel, ...
"Nia Therapeutics publishes first in vivo validation of SNS" was originally created and published by Medical Device Network, ...
Neuralink, a leader in the fledgling field of brain implants, is hurting the industry's efforts to develop useful medical ...
Elon Musk said Neuralink plans to begin high-volume production of its brain-computer interface implants in 2026 and shift to ...
Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results